Assembly Biosciences, Inc.
ASMB
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$28.58
FAIR PRICE
$21.75
MARGIN
$6.83
P/E Ratio
N/A
Div. Yield
N/A
ROE
-5.6%
Market Cap
$450M
Small-cap
COMING SOON
Get notified when ASMB's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Jason A. Okazaki
COUNTRY
US
HEADQUARTERS
South San Francisco
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate ASMB's fair price
Assembly Biosciences, Inc.'s fair price of $21.75 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $28.58, ASMB trades 23.9% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting ASMB's risk profile.
RELATIVE · 30%
Comparing ASMB's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for ASMB, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for ASMB.
Explore on BuliosFAQ
What is the fair price of ASMB?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Assembly Biosciences, Inc. is $21.75. At the current market price of $28.58, ASMB trades 23.9% above its calculated fair value.
Is ASMB overvalued or undervalued?+
Assembly Biosciences, Inc. is currently overvalued based on our valuation model. The stock trades at $28.58, which is 23.9% above the fair price of $21.75.
How often is ASMB's fair price updated?+
We update fair price calculations for ASMB daily after market close. The current fair price of $21.75 incorporates the latest market data and sector multiples.
What factors affect ASMB's fair price calculation?+
ASMB's fair price of $21.75 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -5.6%.
Is ASMB a good buy right now?+
At $28.58, ASMB trades 23.9% above our fair value estimate of $21.75. The stock is currently overvalued. ROE stands at -5.6% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does ASMB pay dividends?+
ASMB does not currently pay a dividend.